NINR Extramural Program: News, Updates, and Opportunities

This monthly newsletter for NINR applicants and awardees provides useful information about funding initiatives and other opportunities.

Funding Opportunities

The NIH Guide recently published the following funding opportunity announcements (FOAs):

New Funding Opportunities

• NOT-OD-22-135: Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity encourages research on the efficacy of interventions that address nutrition security and the mechanisms of food insecurity on a variety of health outcomes. First Application Due Date: October 5, 2022.
• NOT-TW-22-003: NOSI: Climate Change and Health Administrative Supplements invites applications to supplement active NIH awards to seed new activities and partnerships in climate change and health research and research training. Application Due Date: July 27, 2022.
• NOT-OD-22-159: NOSI: Administrative Supplements to Support Research on Preventive Interventions with Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) seeks to support NIH grantees who can add, enhance, or strengthen preventive intervention research with populations that experience health disparities that is within scope of their existing projects. Application Due Date: August 1, 2022.
• NOT-AG-22-025: NOSI: Alzheimer’s-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimer’s Disease invites applications to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias to allow the research to develop such a focus. Application Due Date: October 1, 2022
• NOT-OD-22-167: NOSI: Research on Addressing Violence to Improve Health Outcomes highlights interest in addressing the role of violence in health outcomes and integrating violence-related screening and interventions into health care settings. First Application Due Date: September 7, 2022

• NINR is providing an opportunity for grantees to participate in a free commercialization education and assistance program, Concept to Clinic: Commercializing Innovation (C3i). C3i is an entrepreneurial training course for NINR grantees, designed to provide investigator teams with specialized business frameworks and essential tools that enable the translation of biomedical technologies from the clinic into the marketplace. To be eligible to participate, you must have an NINR-funded grant award (R01, R21, or SBIR/STTR grant) that is active or in a No-Cost Extension through May 1, 2023. Application Due Date: August 5, 2022. Apply Today!

  Please contact Kris Bough (kristopher.bough@nih.gov) if you are interested in participating or have any questions about the application process.

• NOT-NR-22-015: Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting applications for UG3/UH3 phased cooperative research to accelerate implementation of effective, non-opioid interventions for chronic pain management in rural and remote populations. First Estimated Application Due Date: November 15, 2022
  
  

Continuing Funding Opportunities

• RFA-ES-22-003: Research Coordinating Center for the Climate Change and Health Community of Practice (U24 – Clinical Trial Not Allowed) solicits applications from eligible institutions to develop a Research Coordinating Center to support the development of an NIH Climate Change and Health (CCH) initiative Community of Practice (COP) by managing and supporting current CCH research and capacity building efforts, and supporting the expansion of the COP in the long term. Application Due Date: August 25, 2022
• NOT-ES-22-009 and NOT-ES-22-010: NOSI: Innovative Technologies for Research on Climate Change and Human Health supports research to develop or adapt practical technologies for capturing the effects of climate change and extreme weather events on human health and to reduce the health threats posed by climate change across the lifespan. 
  • NOT-ES-22-009: Small Business Technology Transfer (STTR), R41/R42 Clinical Trial Optional. First Available Due Date: September 5, 2022
  • NOT-ES-22-010: Small Business Innovation Research (SBIR), R43/R44 Clinical Trial Optional. First Available Due Date: September 5, 2022
• PAR-22-105 and PAR-22-109: Dissemination and Implementation Research in Health supports studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies.
  • PAR-22-105: R01 Clinical Trial Optional. Next Application Due Date: October 05, 2022
  • PAR-22-109: R21 Clinical Trial Optional. Next Application Due Date: October 16, 2022
• NOT-OD-22-106: NOSI: Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan encourages applications proposing to test multilevel strategies and interventions to improve the uptake of evidence-based screening services across the lifespan and in populations including, but not limited to, those experiencing health disparities and those that are underserved. Multiple application due dates; check NOSI for due dates by specific submission funding opportunity announcement.
• NOT-OD-22-107: NOSI: Addressing Evidence Gaps in Screening solicits applications proposing to strengthen the evidence base for preventive screening services where the evidence is lacking, of poor quality, conflicting, or the balance of benefits and harms cannot be determined. Multiple application due dates; check NOSI for due dates by specific submission funding opportunity announcement.
• NOT-NS-22-087: NOSI: Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain will support supplements to existing HEAL clinical research awards to allow exceptional graduate, post-doctoral, or early career individuals to expand their clinical pain research experience and gain access to the tools and skills needed to prepare them for a career in clinical pain research. Next Application Due Date: February 15, 2023
• PA-22-176: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) invites eligible United States small businesses to submit SBIR grant applications that do not propose a clinical trial. First Application Due Date: September 05, 2022
• PA-22-177: PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) invites eligible United States small businesses to submit SBIR grant applications that propose at least one clinical trial. First Application Due Date: September 05, 2022
• PA-22-178 and PA-22-179: PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications invites eligible United States small businesses to submit STTR grant applications.
  • PA-22-178: Parent STTR [R41/R42] Clinical Trial Not Allowed. First Application Due Date: September 05, 2022
  • PA-22-179: Parent STTR [R41/R42] Clinical Trial Required. First Application Due Date: September 05, 2022

News and Events

Speech Generating Device Helps ICU Patients Communicate with Caregiver To assist conscious hospitalized patients who are unable to independently activate standard nurse call systems, Iowa Adaptive Technologies has developed a device that detects small movements such as finger taps, eye blinks, and tongue clicks, in order to improve patient-provider communication. Funding for this assistive technology was provided through NINR’s Small Business Innovative Research (SBIR) program. Read More

Video Now Available: NINR Director’s Lecture - Social Determinants of Health The video recording of the first NINR Director’s Lecture of 2022 is now available to view. Dr. Vincent Guilamo-Ramos, Dean of the School of Nursing at Duke University, and Dr. Brian Castrucci, President and CEO of de Beaumont Foundation, presented about research priorities and the practice and policy implications of nursing research through the social determinants of health lens. Read More